Recall Z-1542-2018— Ameditech Inc

Class III · Terminated

Class III FDA medical device recall by Ameditech Inc, initiated 2017-12-15, terminated 2019-02-11. It names one FDA 510(k) clearance: K022355. Product: Alere iScreen Dx Urine Drug Screen Card. Reason: The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box..

Recalling firm
Ameditech Inc
Classification
Class III
Status
Terminated
Initiated
2017-12-15
Terminated
2019-02-11
Firm location
San Diego, CA, United States

510(k) clearances named in this recall

1 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

Alere iScreen Dx Urine Drug Screen Card

Reason for recall

The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.

Data sourced from openFDA. This site is unofficial and independent of the FDA.